about
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management.A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis.Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure.Microsimulation for clinical decision-making in individual patients with established coronary artery disease: a concept.Long-term compliance with nonpharmacologic treatment of patients with heart failure.A method for the early health technology assessment of novel biomarker measurement in primary prevention programsThe COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failureA trial-based economic evaluation of 2 nurse-led disease management programs in heart failurePlasma procalcitonin and risk of type 2 diabetes in the general populationPlasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic SyndromeIncidence of impaired renal function after lung transplantation
P50
Q34284033-C094354A-A6A1-445F-BC0C-1AFECF9D7A58Q36522598-EA849C86-FF7F-40BD-B582-77175CBBDC96Q39625891-BF3AB0ED-B8DC-452E-ADEC-D3A6F1425CFFQ44072950-87B83376-0622-428A-B1D2-09CC00B7823BQ44210023-AF95B13D-858C-4FC4-9D5F-6C5121E5A421Q44827816-05672C43-66BD-4CBB-86E6-9220341B237CQ45082070-E4F302A6-161E-4F1E-825C-1A01ADA2640CQ45359460-5CF7FEE9-0C93-4A89-B5C1-E49123361BADQ46178111-AD4F05D1-F866-4979-9D3E-6810855ABF5EQ47881810-9D6B6962-6E2F-4DF8-861A-9D3267E61700Q57259767-D621A02E-6F25-4B52-ABA7-F48316129B8EQ57315233-5235EB57-3FCF-4A4F-A92D-B7C00374C843Q57315238-4633E339-4167-4711-8654-8AAF8BD29369Q57388706-21EC05E1-4169-454C-AE88-CF103D303390Q57388710-57BEB112-BFC8-49E1-B108-E6322A1A4D7CQ85047413-00A91488-C6A7-4756-BEB7-653A2EA2734C
P50
description
researcher, ORCID id # 0000-0002-9458-7038
@en
wetenschapper
@nl
name
Douwe Postmus
@ast
Douwe Postmus
@en
Douwe Postmus
@es
Douwe Postmus
@nl
type
label
Douwe Postmus
@ast
Douwe Postmus
@en
Douwe Postmus
@es
Douwe Postmus
@nl
prefLabel
Douwe Postmus
@ast
Douwe Postmus
@en
Douwe Postmus
@es
Douwe Postmus
@nl
P106
P1153
23482492400
P31
P3835
douwe-postmus
P496
0000-0002-9458-7038